- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Vimentin (VIM) is a type III intermediate filament protein that forms a cytoplasmic structural network in mesenchymal cells, supporting cellular integrity, migration, and intracellular organization. Vimentin Antibody Clone VM452 is developed for researchers seeking a clone-specific reagent with emphasis on tissue-based validation, making it highly relevant for searches such as VM452 antibody, Vimentin clone VM452 antibody, and VIM clone VM452 antibody. Vimentin is also referred to as Vimentin antibody, VIM antibody, and mesenchymal marker antibody in the literature, helping unify gene, protein, and functional terminology for improved search alignment.
Vimentin is broadly expressed in fibroblasts, endothelial cells, leukocytes, and other mesenchymal-derived cell types, while epithelial cells typically lack expression unless undergoing epithelial-mesenchymal transition or pathological remodeling. This expression profile makes Vimentin one of the most widely used markers in tumor pathology research, particularly for identifying mesenchymal differentiation, stromal components, and invasive tumor phenotypes. Its cytoplasmic filamentous staining pattern is a hallmark feature in immunohistochemistry-based studies of both normal and diseased tissues.
Functionally, Vimentin interacts with actin filaments and microtubules to regulate cell shape, adhesion, and motility. Its dynamic reorganization through phosphorylation supports processes such as mitosis, migration, and cellular stress responses. Vimentin is also involved in wound healing, immune regulation, and developmental transitions, further reinforcing its importance as a multifunctional cytoskeletal protein in both physiological and pathological contexts.
The clone VM452 monoclonal antibody serves as a key differentiator in this product, with clone VM452 referenced in peer-reviewed literature and supported by tissue microarray (TMA) specificity testing across a wide range of normal and cancer tissues. This TMA-based validation approach provides valuable context for tissue-level expression patterns and staining consistency, which is especially important for researchers performing immunohistochemistry and comparative tissue analysis. Incorporating clone VM452 into experimental workflows supports clone-specific reproducibility while leveraging tissue-wide specificity data, offering a well-defined option for detecting Vimentin / VIM expression in studies that prioritize histological context and broad tissue screening.
The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the Vimentin Antibody Clone VM452 to be titered up or down for optimal performance.
Recombinant protein was used as the immunogen for the Vimentin Antibody Clone VM452.
Store the Vimentin antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
VIM antibody, Vimentin intermediate filament antibody, Mesenchymal marker antibody, Type III intermediate filament antibody, Fibroblast marker antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.